Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/13/2025

Ciprofloxacin Prophylaxis in Ascites

Indications and Patient Selection

  • The American Association for the Study of Liver Diseases recommends ciprofloxacin prophylaxis (500 mg/day orally) in patients who have survived an episode of spontaneous bacterial peritonitis (SBP), and in patients with low protein levels in ascitic fluid (<15 g/L) who also have advanced liver disease (Child-Pugh ≥9 with bilirubin ≥3 mg/dL) or renal dysfunction (creatinine ≥1.2 mg/dL, BUN >25 mg/dL, or sodium <130 mEq/L) 1, 2
  • Patients who survive an episode of SBP have a recurrence rate of 70% per year without prophylaxis, which can be reduced to 20% with ciprofloxacin 500 mg once daily 3, 4, 5
  • The European Association for the Study of the Liver recommends considering liver transplantation in all patients with a history of SBP 3, 4, 5

Primary Prophylaxis

  • The American Association for the Study of Liver Diseases recommends primary prophylaxis in patients with low protein levels in ascitic fluid (<15 g/L) and at least one of the following: Child-Pugh ≥9 points with bilirubin ≥3 mg/dL, creatinine ≥1.2 mg/dL, BUN >25 mg/dL, or sodium <130 mEq/L 1, 7, 2
  • Ciprofloxacin reduces the probability of SBP at 1 year from 61% to 7% in high-risk patients 2, 6
  • Ciprofloxacin also reduces the risk of hepatorenal syndrome and improves survival at 3 months from 62% to 94% 2, 6

Dosage and Alternatives

  • Ciprofloxacin: 500 mg orally once daily 3, 4, 5, 6
  • Alternatives if ciprofloxacin is not available: norfloxacin 400 mg/day (first-line in European guidelines) 3, 1, 4, 5, trimethoprim-sulfamethoxazole (800/160 mg) once daily 7, 6

Warnings and Limitations

  • Prolonged use of quinolones selects for resistant flora, increasing the risk of gram-positive infections, including methicillin-resistant Staphylococcus aureus 3, 5
  • Ciprofloxacin can cause musculoskeletal and neurological adverse effects, which are potentially irreversible, and the risk increases in patients with renal insufficiency 1, 6
  • Ciprofloxacin should be discontinued immediately in case of tendon pain or inflammation 1, 6

Additional Considerations

  • Regular monitoring of renal function is recommended in patients on antibiotic prophylaxis 6, 8
  • Paracentesis should be performed in case of clinical deterioration, development of encephalopathy, renal failure, or peripheral leucocytosis 4
  • Proton pump inhibitors should be restricted, as they may increase the risk of SBP 1, 6, 8